← All Photon Counting CT Digests | 8 articles 10 categories

What's New in Photon Counting CT? — October 14, 2026

AI-summarised digest of 8 PubMed articles on Photon Counting CT published in the last 7 days.

What’s New in Photon Counting CT?

October 14, 2026 · 8 articles · 10 research themes · covering October 07, 2026 – October 14, 2026

Overview

Across this week’s set of studies and reviews, a clear theme is the push to make photon-counting CT (PCD-CT/PCCT/SPCCT) more quantitative and clinically actionable by leveraging its intrinsic spectral information. Multiple works focus on iodine-related performance—establishing detection thresholds, quantification precision, and linearity (enabling more reliable iodine maps)—while other research explores how spectral parameters can distinguish clinically important tissue states, such as recurrent pancreatic ductal adenocarcinoma versus benign post-surgical fibrosis.

Method development and translation are also prominent. Phantom and preclinical evaluations test how acquisition and reconstruction choices (tube voltage ranges, filtration, slice thickness, and kernels) affect contrast-to-noise and image quality, including in challenging anatomical targets like temporal bone structures for cochlear implant assessment. In parallel, a motion-correction reconstruction approach for photon-counting detector CT improves visualization of native and prosthetic heart valves during rapid motion, highlighting that performance gains are not only spectral but also computational.

Finally, the digest underscores broader clinical context: reviews synthesize cardiothoracic and oncology use-cases for PCD-CT, emphasizing potential advantages over energy-integrating CT (e.g., low-keV virtual monoenergetic imaging, iodine mapping, and material decomposition). Complementing this, a narrative review on contrast-agent strategies in oncology reminds that even with advanced imaging hardware, practical outcomes depend heavily on protocol implementation—especially contrast timing and phase selection—while a K-edge lung imaging phantom study points toward future functional imaging capabilities using optimized high-Z agents and exposure settings.


Quantitative Iodine Detection, Thresholds, and Linearity

Evaluation of iodine detection and quantification limits in photon-counting CT-a phantom study.

This phantom study evaluated iodine detection threshold, quantification precision, and measurement linearity in photon-counting CT (PCCT) compared with dual-energy CT (DECT) using head and abdominal protocols with iodine test-tube concentrations spanning 0.0–2.0 mg/mL. The key finding was that iodine quantification performance can be characterized using laboratory-style detection/quantification concepts, enabling direct comparison of how accurately different CT detector technologies detect and measure iodine as an analyte. This is scientifically and clinically important because CT iodine maps underpin decisions in contrast-enhanced imaging, and establishing detection/quantification limits supports more reliable quantitative interpretation.

Titternes R, Poludniowski G, Brismar TB et al. · European radiology experimental · (2026) · View on PubMed ↗


K-edge / High-Z Spectral Imaging for Functional Lung Assessment

Color K-edge imaging using spectral photon-counting CT with high-Z elements for lung functional imaging: A phantom study.

This phantom study evaluated the feasibility of “color” K-edge imaging for lung functional imaging using spectral photon-counting CT (SPCCT) with eight candidate high-Z elements (gadolinium, holmium, ytterbium, hafnium, tantalum, tungsten, gold, bismuth) at 120 kVp and three radiation exposure levels (50, 75, 150 mAs). The key results were measured as noise, contrast-to-noise ratio (CNR), and relative percentage error (RPE) across iodine/element concentrations (0–2 mg/mL), demonstrating element-dependent performance for K-edge–based contrast. This work is significant because it identifies which high-Z agents and acquisition settings best enable quantitative lung functional imaging with SPCCT.

Gutwinska AJ, Rosario D, Robert A et al. · Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB) · (2026) · View on PubMed ↗


Post-Surgical Surveillance: Differentiating Recurrence vs Fibrosis

A Pilot Study of Photon Counting CT Spectral Analysis Following Pancreatic Adenocarcinoma Resection to Differentiate Local Recurrence From Postsurgical Fibrosis.

This pilot retrospective study assessed photon-counting CT (PCCT) spectral parameters to differentiate locally recurrent pancreatic ductal adenocarcinoma (PDAC) from benign postsurgical fibrosis after PDAC resection in 22 patients. Using blinded radiologist regions of interest in the surgical bed soft tissue, the study found that PCCT-derived iodine density (iodine content normalized to aortic enhancement) and related spectral metrics differed between recurrence (confirmed by histopathology or enlarging FDG-avid tissue) and nonrecurrence (soft-tissue reduction with stable/decreasing CA 19-9). Clinically, these spectral biomarkers could improve noninvasive post-surgical surveillance by reducing reliance on repeat biopsy or surgery when distinguishing recurrence from fibrosis.

Platt S, Bansal B, Bagga B et al. · Journal of computer assisted tomography · (2026) · View on PubMed ↗


Cardiothoracic Imaging Applications (Heart Valves, Cardiac/Thoracic Workflows)

Improved Visualization of Heart Valves With 4D-CT Using a Novel Motion Correction Algorithm.

This retrospective single-center study evaluated whether a novel reconstruction-based motion correction algorithm improves image quality and reduces motion artifacts for native and prosthetic heart valve assessment in photon-counting detector CT (PCD-CT) versus standard reconstructions in 57 patients. The key result was that motion correction improved visualization of heart valves during phases of rapid motion, yielding fewer motion artifacts and better image quality for evaluating valvular movement and pathology. This matters because more accurate valve imaging can improve diagnosis and treatment planning in patients with native valve disease and prosthetic valve dysfunction.

Zedler D, Demmert TT, Ritter A et al. · Investigative radiology · (2026) · View on PubMed ↗ · Free PDF ↗


Temporal Bone & Cochlear Implant Imaging

Improved assessment of the cochlear implant and temporal bone structures with ultra-high resolution photon-counting detector CT compared to conventional CT systems.

This study compared photon-counting detector CT (PCD-CT) with conventional energy-integrating CT systems for imaging cochlear implant and temporal bone structures using three post-mortem human specimen heads and three cochlear implant models scanned on SOMATOM Edge, SOMATOM Force, and NAEOTOM Alpha. PCD-CT reconstructions across multiple tube voltages (120–150 kV), tin filtration, slice thicknesses (0.2–0.6 mm), and reconstruction kernels produced improved bone-to-soft-tissue contrast-to-noise ratios (CNR) and image quality relative to conventional CT. These findings support optimizing PCD-CT scan parameters to improve preoperative/postoperative cochlear implant assessment and temporal bone evaluation.

van der Bie J, van der Eerden AW, van den Berg AS et al. · European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · (2026) · View on PubMed ↗


Contrast Agent Strategy and Timing in Oncology Imaging

[Contrast agent strategies in elective oncological imaging].

This narrative review article discussed contrast agent strategies for elective oncological imaging, focusing on how intravenous contrast is used across CT and MRI to answer specific clinical questions. The key finding was that practical protocol implementation—particularly the choice of contrast phase—varies in routine despite guideline-based recommendations for imaging frequency and modality. This is significant because optimizing contrast timing and selection can improve detection and characterization of intraparenchymal lesions and thereby influence staging and response assessment.

Gerwing M, Eisenblätter M · Radiologie (Heidelberg, Germany) · (2026) · View on PubMed ↗


Clinical Reviews and Expert Panels on PCD-CT Adoption

Practical applications of photon-counting CT in oncology: an organ-based pictorial review.

This organ-based pictorial review summarized practical oncology applications of photon-counting detector CT (PCD-CT) and how its spectral/material-specific capabilities extend contrast-enhanced CT beyond morphology. The key finding is that PCD-CT can provide improved low-keV virtual monoenergetic imaging, iodine mapping, and material decomposition with potential advantages over energy-integrating detector CT (EID-CT) limitations such as increased low-keV noise and workflow complexity. The review is significant because it consolidates evidence and use-cases that can guide clinical adoption of PCD-CT for tumor conspicuity, extent assessment, and tissue characterization.

Kawasaki Y, Yokoyama K, Hada H et al. · Insights into imaging · (2026) · View on PubMed ↗ · Free PDF ↗

Photon-Counting Detector CT in Cardiothoracic Imaging: AJR Expert Panel Narrative Review.

This AJR Expert Panel narrative review summarized the clinical impact of photon-counting detector CT (PCD-CT) in cardiothoracic imaging compared with conventional energy-integrating detector CT (EID-CT). The key finding was that PCD-CT’s improved spatial/contrast resolution, intrinsic spectral information, and potential for reduced radiation dose and contrast volume translate into better visualization of pulmonary and cardiac anatomy across multiple clinical scenarios. This review is significant because it synthesizes early evidence to support safer and more effective cardiothoracic imaging workflows with PCD-CT.

Milos RI, Siegel MJ, Bluemke DA et al. · AJR. American journal of roentgenology · (2026) · 1 citations · View on PubMed ↗



Generated automatically on October 14, 2026. Covers PubMed articles published October 07, 2026 – October 14, 2026. Summaries are AI-generated; always consult the original publication for clinical or research decisions.